Results for "consumer data right"
311-320 of 758 results for 'consumer data right'
An overhaul of regulation of software as a medical device - what's on the horizon?
Proposed new regulatory rules for software as a medical device will if enacted have serious implications for suppliers to the Australian market who will likely have to meet more stringent requirements that could conflict with those in the US and Europe Special Counsel Ric Morgan and Senior Associate ...
Fonterra v Vitasoy: Turns out you really can grow milk
The Registrar's recent decision in Fonterra Co-Operative Group Limited v Vitasoy International Singapore Pte Ltd reaffirms an assumption of level-headedness in the average consumer, capable of identifying and embracing the spirit of trade marks containing connotations rather than being misled ...
Healthcare trend watch 2019
The healthcare team at Allens reports on some key trends and sectors to look out for in 2020. ...
APRA proposes cross-industry framework for management of information security
APRA has released for consultation its first prudential standard of information security Prudential Standard CPS 234 Information Security CPS 234 - a key response to the growing threat of cyber attacks ...
PBS process proving a headache for migraine medications
Challenging a PBAC decision is not straightforward. We take a look at the available options and examine the alleged delays in listing migraine treatments Emgality and Ajovy on the PBS. ...
Allens advises Power Ledger on A$34 million blockchain ICO
Allens has advised Power Ledger on its ground-breaking Token Generation Event, one of Australia's first Initial Coin Offerings (ICOs), which raised A$34 million for the company. Power Ledger is a ...
TGA guidance on the promotion of medicinal cannabis
The Therapeutic Goods Administration (TGA) has issued guidance on advertising to the public for businesses involved with medicinal cannabis products and therapies. Along with advertising restrictions, ...
TGA guidance on the promotion of stem cells and HCT products
The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...
Takeaways from recent guidance on cyber incident disclosure obligations for listed companies
In this Insight, we examine the guidance note and related developments and offer our view as to when disclosure (for the purposes of the ASX listing rule requirements) of cyber incidents should generally only occur. ...
Making the quantum computing leap
The Federal Government's recent National Quantum Strategy and FY2023–24 Budget signal a strong commitment to growing Australia's quantum computing sector. To assist organisations aiming to capitalise on that renewed focus, this Insight gives an overview of the technology and the legal issues. ...